Search

everythinglearnresearchcommunity

for

Search:↓

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Most patients improved with oral contraceptives, but some needed additional treatment.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hormones control reproduction and are crucial for body balance.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Bicalutamide may help treat female pattern hair loss.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Certain maturity signs appear before and after the first release of sperm in boys.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.